BMY
BRISTOL MYERS SQUIBB CO
NYSE · Healthcare · Drug Manufacturers - General · US
$63.64
−0.17%Price chart
Aug 12Aug 17Aug 20Aug 25Aug 28Sep 2Sep 8Sep 11
ValuationView details →
P/E (Fwd)
9.9x
EV/EBITDA
9.7x
Market Cap
$130.00B
MomentumView details →
1D Return
−0.17%
YTD Return
+17.61%
RSI (14)
41.6
ValuationView details →
P/E (Fwd)
9.9x
EV/EBITDA
9.7x
Market Cap
$130.00B
RSI (14)
41.6
MomentumView details →
1D Return
−0.17%
YTD Return
+17.61%
SummaryUpdated Jun 1, 2026
Bristol-Myers Squibb Company (NYSE:BMY) is a global biopharmaceutical company founded in 1887 and headquartered in New York. The company was formed through the merger of Bristol-Myers Company and Squibb Corporation, with Bristol-Myers Company tracing its origins to the Clinton Pharmaceutical Company established by William McLaren Bristol and John Ripley Myers. Today, Bristol-Myers Squibb stands as one of the world's leading pharmaceutical companies, focusing on discovering, developing, and commercializing innovative medicines for serious diseases including cancer, cardiovascular conditions, immunological disorders, and neurological conditions.
Similar companies
Latest newsMore news →
Bristol-Myers Squibb announced positive topline results from its registrational Phase 2 QUINTESSENTIAL trial for a potential first-in-class drug.5d agoRayzeBio Inc., a subsidiary of Bristol Myers Squibb, announced plans to build a new 225,000 square-foot radiopharmaceutical manufacturing facility in Whitestown, Indiana, with construction expected to begin this year and completion by the end of 2029.14d agoBristol Myers Squibb announced a $2.3 billion investment to build a new manufacturing campus in Houston, Texas, advancing its U.S. manufacturing expansion.34d ago